ArticleJMIR formative research2026
Adaptation of an HIV Prevention Ambassador Program Developed in Africa for Use With Cisgender College Women in the United States: Formative Study.
Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: Cisgender college women are vulnerable to HIV transmission but rarely use biomedical prevention tools such as pre-exposure prophylaxis (PrEP). In the Orlando Metropolitan Statistical Area (MSA) of Florida, HIV vulnerability is elevated given the area's high incidence rate (sixth among US cities). Increasing HIV and PrEP knowledge among cisgender college women can curb HIV incidence. One method of providing HIV education to cisgender college women and addressing the HIV and PrEP-related stigma is by training ambassadors through programs such as Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC), which was developed for women and girls in Africa. Objective: The research aim was to adapt the existing MOSAIC HIV prevention ambassador program to reflect the needs of cisgender college women in Orlando MSA and to determine its acceptability, appropriateness, and feasibility for this population. Methods: The assessment, decision, administration and adaptation, production, topical experts, integration, training, and testing (ADAPT-ITT) framework for adapting evidence-based interventions guided the research. Cisgender college women (n=12) participated in focus groups that included theater testing, discussion, and surveys. Program materials were revised based on feedback, then reviewed by topical experts (n=5) who assessed feasibility and appropriateness. Data analysis was iterative; qualitative data were analyzed using rapid methods, and descriptive survey statistics complemented findings to inform curriculum revisions. Ambassadors (n=7) were trained with the adapted curriculum and provided data on acceptability and appropriateness. Results: Data from cisgender college women and topical experts indicated the program's acceptability (mean 5.0, SD 0), appropriateness (mean 4.95, SD 0.06), and feasibility (mean 4.95, SD 0.10) and informed program adaptations. Themes from the qualitative data indicated the value of the ambassador program as well as the following recommendations: (1) provide more guidance for activities, (2) add HIV and PrEP information specific to the target population, (3) prioritize interpersonal engagement, and (4) emphasize ambassador wellness. Ambassadors reported high levels of acceptability (mean 4.75, SD 0.66) and appropriateness (mean 4.86, SD 0.38) for the adapted program after being trained and reported increases in confidence in some areas. Conclusions: Study findings provide preliminary support for the acceptability, feasibility, and appropriateness of the adapted ambassador training program. Further testing of the program can determine its use as a scalable, peer-led strategy to address HIV vulnerability and PrEP stigma in metropolitan areas with elevated HIV incidence, such as Orlando MSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.